-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 D6Q2Y46Gd6/h3UrSsHEZfBki30lY5yyFEyfgkjrRzDPBOoGSsW/4LKK3Tq6N3wTy
 FnR9bis99xEfxfqr04Nt0w==

<SEC-DOCUMENT>0001096906-10-000037.txt : 20100312
<SEC-HEADER>0001096906-10-000037.hdr.sgml : 20100312
<ACCEPTANCE-DATETIME>20100113110046
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001096906-10-000037
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20100113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UTAH MEDICAL PRODUCTS INC
		CENTRAL INDEX KEY:			0000706698
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870342734
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		7043 S 300 WEST
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8015661200
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
<head>
    <title>utmdcorresp20100112.htm</title>
<!-- Licensed to: Southridge Services-->
<!-- Document Created using EDGARizerAgent 5.1.3.0 -->
<!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div>
      <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
      <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center"><img src="logo.jpg" alt=""></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">January
13, 2010</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Eric
Atallah, Staff Accountant</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Division
of Corporation Finance</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">U.S.
Securities and Exchange Commission</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Washington,
D.C. 20549-0306</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIA
FACSIMILE [703-813-6985] and U.S. Certified Mail</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Re: Utah
Medical Products, Inc.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form 10-K
for the year ended December 31, 2008</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">File No.
001-12575</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear Mr.
Atallah:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Thank you
for your review of Utah Medical Products, Inc.&#8217;s (UTMD&#8217;s) recent SEC Form 10-K
filing.&#160;&#160;This is UTMD&#8217;s requested response to the SEC comments, which
will also be filed on EDGAR as private correspondence with the SEC.&#160;&#160;I
have incorporated the SEC comments received December 18, 2009 in italics
followed by UTMD&#8217;s responses.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Form 10-K for the year ended
December 31, 2008</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Business, page
1</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
            <td style="WIDTH: 18pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">1.</font></div>
            </td>
            <td>
              <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
      note from your disclosure in the first full paragraph on page 17 that you
      appear to have recently lost significant sales of IUPCs and VADs to a
      competitor.&#160;&#160;However, it does not appear you have provided in
      the business section a complete discussion of the competitive conditions
      in your industry required by Item 101(b)(x) of Regulation
      S-K.&#160;&#160;Please provide such disclosure in future
      filings.</font></div>
            </td>
          </tr></table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
1</font>:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UTMD will
ensure that future filings include in the business section a discussion of
competitive conditions in its industry as required by Item 101(c)(1)(x) of
Regulation S-K.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ITEM 1A Risk
Factors,&#160;&#160;page 11</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
            <td style="WIDTH: 18pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font></div>
            </td>
            <td>
              <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">We refer to your brief risk
      factor disclosure.&#160;&#160;In future filings, please provide your risk
      factors in the format required by Item 503(c) of Regulation S-K including
      setting out each risk factor under a separate subcaption that adequately
      describes the risk.&#160;&#160;You should also expand your disclosure to
      more clearly describe how the risk affects you and avoid discussing risks
      that could apply to any
issuer.</font></font></div>
            </td>
          </tr></table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
2</font>:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UTMD will
ensure that future filings include adequate disclosure of risk factors in the
format required by Item 503(c) of Regulation S-K including descriptions of how
those risks affect the Registrant.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Item 7. Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations, page
15</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
            <td style="WIDTH: 18pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font></div>
            </td>
            <td>
              <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">It is unclear where you have
      provided an overview section of MD&amp;A.&#160;&#160;The overview in this
      section should be a balanced, executive- level discussion that identifies
      the most important themes or other significant matters with which
      management is concerned primarily in evaluation the company&#8217;s financial
      condition and operating results.&#160;&#160;Discuss material business
      opportunities, challenges and risks, such as those presented by known
      material trends and uncertainties, on which the company&#8217;s executives are
      most focused, and the actions they are taking in response to
      them.&#160;&#160;For further guidance on the content and purpose of the
      &#8220;Overview,&#8221; see Commission Guidance Regarding Managements Discussion and
      Analysis of Financial Condition and results of Operations Interpretive
      Release No. 33-8350 (December 19, 2003) on our website.&#160;&#160;In
      future filings, please provide such a
  discussion.</font></font></div>
            </td>
          </tr></table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: gray" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
3</font>:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UTMD will
ensure that future filings include required MD&amp;A overview
disclosure.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Gross
Profit, page 18</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
            <td style="WIDTH: 18pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">4.</font></div>
            </td>
            <td>
              <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
      note that your gross margin was affected by a product recall in
      2008.&#160;&#160;Please tell us and revise future filings, as necessary to
      describe the nature and extent of your warranty obligations and your
      methodology for estimating your warranty obligation.&#160;&#160;In light
      of your recent product recall, please explain to us why no warranty
      accrual was required as December 31,
2008.</font></div>
            </td>
          </tr></table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
4</font>:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UTMD&#8217;s
warranty:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;UTMD
warrants its products to conform in all material respects to all published
product specifications in effect on the date of shipment, and to be free from
defects in material and workmanship for a period of thirty (30) days for
supplies, or twenty-four (24) months for equipment, from date of
shipment.&#160;&#160;During the warranty period UTMD shall, at its option,
replace any products shown to UTMD's reasonable satisfaction to be defective at
no expense to the Purchaser or refund the purchase price.&#8221;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160; </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UTMD will
ensure that future filings include the nature and extent of its warranty
obligations and the methodology it uses for estimating its warranty
obligations.&#160;&#160;&#160;UTMD believed that no warranty accrual was
necessary at December 31, 2008 based on its analysis of historical warranty
claims and its estimate that existing warranty obligations at 12/31/08 were
immaterial.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Note
8&#160;&#160;&#160;Income Taxes, page 39</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
            <td style="WIDTH: 18pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">5.</font></div>
            </td>
            <td>
              <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Please
      revise future filings to include disclosure of the components of
      income(loss) before income tax expense (benefit) as either domestic or
      foreign as required by Rule 4-08(h)(1)(i) of Regulation
  SX.</font></div>
            </td>
          </tr></table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
5</font>:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UTMD will
ensure that future filings disclose the components of income (loss) before
income tax expense (benefit) as either domestic or foreign as required by Rule
4-08(h)(1)(i) of Regulation S-X.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Note 9&#160;&#160;Options,
page 40</font></font></div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
            <td style="WIDTH: 18pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">6.</font></div>
            </td>
            <td>
              <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
      note that you utilize the Black Scholes option pricing model to determine
      the fair value of your stock options.&#160;&#160;Please tell us and revise
      future filings to explain how you determined the assumptions utilized in
      the model including the volatility, risk free interest rate, expected
      life, etc.&#160;&#160;Refer to the guidance in 718-10-50-2 of the FASB
      Accounting Standard Codification.</font></div>
            </td>
          </tr></table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
6</font>:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All UTMD
options vest over a four-year service period.&#160;&#160;UTMD estimated
volatility based on its historical volatility over recent periods of time and
trends in that volatility, giving weight to more recent periods.&#160;&#160;Risk
free interest rates were estimated based on actual U.S. Treasury Securities
Interest rates as reported by the Federal Reserve Bank for periods of time
equivalent to the holding periods estimated for the options on the dates the
options were granted.&#160;&#160;Expected term of options were estimated based
on historical holding periods for similar options previously granted by UTMD to
employees and directors.&#160;&#160;Expected dividend amounts were estimated
based on the actual cash dividend rate at the time the options were granted and
an estimate of future dividends based on past dividend rate changes as well as
management&#8217;s expectations of future dividend rates over the expected holding
period of the options.&#160;&#160;UTMD will ensure that future filings include
explanations of how UTMD determined the variables used in determining fair value
of stock options.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: gray" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Note 14 &#8211; Fair Value
Financial Instruments, page 41</font></font></div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
            <td style="WIDTH: 18pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">7.</font></div>
            </td>
            <td>
              <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
      note your disclosure that none of your financial instruments are held for
      trading purposes, except for investments.&#160;&#160;Given that your
      disclosures in Notes 1 and 4 indicate that your investments are classified
      as available for sale, your current disclosure in this note may be
      confusing to investors.&#160;&#160;Please revise future filings
      accordingly.</font></div>
              <div align="left">&#160;</div>
            </td>
          </tr></table></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
7</font>:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In future
filings UTMD will note that none of its financial instruments are held for
trading purposes.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Signatures, page
48</font></font></div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
            <td style="WIDTH: 18pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.</font></div>
            </td>
            <td>
              <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Please tell us how you believe
      the signatures comply with the requirements of Form 10-K.&#160;&#160;For
      example, we note you have not included the signatures of your principal
      executive officer and principal financial officer below the second
      paragraph of text on the signature page as required by the language in
      General Instruction D(2)(a) to Form 10-K.&#160;&#160;Please tell us how
      your signature will appear in future
  filings.</font></font></div>
            </td>
          </tr></table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
8</font>:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UTMD will
include the additional titles of Chief Executive Officer to Kevin Cornwell&#8217;s
signature and Principal Financial Officer to Paul Richins&#8217; signature below the
second paragraph of text on the signature page of future Form 10-K
filings.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibits 15 and
16</font></font></div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
            <td style="WIDTH: 18pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">9.</font></div>
            </td>
            <td>
              <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
      note that you have added the word &#8220;known&#8221; in paragraphs 5(a) and 5(b) of
      each of the certifications signed by your chief executive officer and
      principal financial officer that were filed as exhibits to your annual
      report of Form 10-K for the year ended December 31, 2008. As noted in the
      March 4, 2005 Staff alert entitled Annual Report Reminders, the staff of
      the Division of Corporation Finance reminded issuers that the
      certifications required under Exhibit Act Rules 13a-14(a) and 15d-14(a)
      must be in the exact form set forth in Item 601(b)(31) of Regulation
      S-K.&#160;&#160;This document is available on our web site at <font style="DISPLAY: inline; TEXT-DECORATION: underline">http://www.sec.gov/divisions/corpfin/cfalerts/efalert030405.htm</font>.
      Accordingly, please file an amendment to your annual report on Form 10-K
      that includes the entire periodic report and new corrected
      certifications.</font></div>
            </td>
          </tr></table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD Response to Item
9</font>:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Amendment
A to UTMD&#8217;s Form 10-K for December 31, 2008 was filed on January 13,
2010.&#160;&#160;Exhibits 15 and 16 to that report were in the exact form set
forth in Item 601(b)(31) of Regulation S-K.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">In
connection with responding to our comments, please provide, in writing, a
statement from the company acknowledging that:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#183;&#160;&#160;the
company is responsible for the adequacy and accuracy of the disclosure in the
filing;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD
Response</font>:&#160;&#160;UTMD understands that the Company is responsible for
the adequacy and accuracy of the disclosure in the filing.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#183;
staff comments or changes to disclosure in response to staff comments do not
foreclose the Commission from taking any action with respect to the filing;
and</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Response</font>:&#160;&#160;UTMD
understands that staff comments or changes to disclosure in response to staff
comments do not foreclose the Commission from taking any action with respect to
the filing.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#183; <font style="DISPLAY: inline; FONT-STYLE: italic">the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any
person under the federal securities laws of the United
States.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Response</font>:&#160;&#160;This
last statement is somewhat confusing, as UTMD clearly relies on SEC staff
comments to represent what it needs to do to satisfy SEC disclosure
requirements.&#160;&#160;Consistent with prior UTMD responses to SEC comments,
UTMD is unwilling to acknowledge this last statement, as we believe it may also
represent a violation of UTMD&#8217;s Constitutional rights.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: gray" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Very
respectfully, UTMD believes that the third bullet point acknowledgement may be a
violation of its rights to due process under the U.S.
Constitution.&#160;&#160;If you disagree, please identify what law or regulation
requires UTMD to acknowledge it cannot use SEC comments as a defense in any
proceeding initiated by the Commission.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
issue of not acknowledging your third bullet point is hopefully moot, assuming
that SEC concludes UTMD is substantially in compliance with applicable SEC
regulations. If SEC concludes otherwise, please provide further comments so that
we can make the necessary corrections to our public disclosures to get into
compliance before you consider consuming dear taxpayer funds going to
court.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Please
understand that the purpose of our response is to fully comply with all
applicable U.S. laws and regulations. We look forward to continuing to work with
the SEC in these respects.&#160;&#160;Please feel free to contact me directly at
the numbers listed at the end of this letter.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Thank you
for your review of the referenced disclosures.&#160;&#160;I hope that the above
responses are complete and to the satisfaction of the SEC.&#160;&#160;If not,
please give us the opportunity to augment the responses as needed.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sincerely,</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="TEXT-DECORATION: underline">/s/ Paul O.
Richins</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Paul O.
Richins</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Principal
Financial Officer</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Direct
tele no. (801) 569-4200</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fax no.
(801) 566-7305</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
      <hr style="COLOR: gray" noshade size="2">
    </div>
  </body>
</html>


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``P("`P("
M`P,"`P,#`P,$!P4$!`0$"08'!0<*"0L+"@D*"@P-$0X,#!`,"@H.%`\0$1(3
M$Q,+#A06%!(6$1(3$O_;`$,!`P,#!`0$"`4%"!(,"@P2$A(2$A(2$A(2$A(2
M$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$O_``!$(`'L`
M=P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/U3HHHH`**Y37_B7I'AO4Y+#4;/Q7-/$%+/8>$]3OHCD9&)8+=X
MSUY`8XZ'!K/_`.%T>'_^@?X[_P#""UK_`.1*`.[HKA/^%T>'_P#H'^.__"!U
MK_Y$I/\`A='A_P#Z!_CO_P`('6O_`)$H`[RBN#_X73X?_P"@?X[_`/"!UK_Y
M$H_X73X?_P"@?X[_`/"!UK_Y$H`[RBN$_P"%T>'_`/H'^.__``@M:_\`D2D_
MX71X?_Z!_CO_`,('6O\`Y$H`[RBN$_X71X?Q_P`@_P`=_P#A!:U_\B4?\+H\
M/_\`0/\`'?\`X0.M?_(E`'=T5E>'/$EIXIT\WNF0ZI#")#'MU+2KG3Y<@`Y\
MNXC1\<_>Q@\X/!K5H`****`"BBB@#Q7X:^(+>T_:!^-.EZKJ20W/VK2KZUL[
MFYVM]D_LVW1IHT8_ZOS4D4L.-RL#S7CFI^"?#OB7_A0^JZ[IT5Z_BGQSJ<=W
M<W#OF_L#::M/`K_-\T>%AD4'CY5/:M;XS_%#[7\1OB'IT_ASX?\`B'5O`$&G
M#P[HVJ:$U]J.N/<P+*;>)P^4+.Y12$903N8$`UG0?M6O>:;+K'B+1_"WB&P\
M'W7B-_$.AV&G,;OPS9V`OH;>X,S.T8,XMQ!M*J6-PVT[5<4`6(O&FN>&_B.O
MBN_AU&Q\`?%/2KG0-(:6_1K6V>VAEETB2&,'=&9X5NRQ;&7EA'856M-9^(!_
M9V^!$VM+X;BTBYU7P:)+NTU:Z>\EC:XM=NX-&%9FR-X+D'+=>_I'BWQ+XD\$
M?"C0_%_Q,TOP=J>@VUQILNJ^&[?2SMTB&6:*-'MI69A(]N9$;E%W!&V[#M%<
MW%\8O%-G^SS:_%#4],\%7OAK0;V66\\.0Z3)$UM9VE^]N'M93*RB6-(A(H,8
M!*[05X(`/1_VEXM?U3PKX?T7P!JQT;Q+K'B*W.EW&["M-:QRWJQR>L3FT"..
MZ.U?/WQC^-VJ?$;PYH/C+1Y]7\.>%[K2/$>@RZ9-N@D?5O[$O)IB_0DV\UJU
MNI'&]9B,_*:]PT/XO7OB;X":S\0]0TK1GU?PW?:X-/1HF:-/L=Y=6L;C)+*S
M11_,5(^^P&`<5!X%U3Q!\>_!]AXNT^W\&6'AR[U2XET;2-5T)K]Y+59I(6N)
M)/-41S2H96`52%$FUBV6H`\CT;P=I4<7[/%AKFC>&;2R\0ZPTNHVNGZC)<PZ
MCM\/W3H]R'5`7WC=CYAD`Y)JA\0[J[\)?%/5-'^$=S<2^%].\4>&'M+%+QWM
M;?79!?F:UA.X@(T:6;21`[59P<`L<]%J>I:QX7F^*%A%X+^&FL6/PVN=+D:S
MTKP._F7/VJW1I+H1+,Q)@CD=MB*6=$905+5[?\)KWP_XI^&-KJ6AWG@OQ1I5
MG=376F76AZ8MO;1R1DE3Y.YO*G0Y#8((.>%/%`'"_`S3_`B?`GP7\0_&%S:Z
MAKMOI4>K:QXAOK@F\_M$0EKM7?(8,K^:A@Z+MV[1M`'B?Q0\7^,/!/@GXP6?
MQ$75]%_X6EX*O?$FB"ZU)'^Q:A;1JES:0%&S&!:M9LJG!S#.WK7=_"[XQ^'_
M`!5XDT*]^*?P]\'Z;9>-M'T:>'Q);V"-'_;-_9I.]I<[P2GF;]L4A/SD&-CN
M*[NJ\(>/-6_:0UO6-%&E>$;.W\&1[+^^U;1O[3WWEPTZ+#!"[J$06RKYCEB6
M,VP``$T`?1L,\5PI:WDCE4'!*,&`/IQ4E9'A;P_:^&M$M[.QT_2=-8J)+F+2
MK06]NTY`\QE0=`6SUR<8R36O0`4444`%%%%`'CJ:5J'P^^+'C;Q'H7@_QAXD
M?QA]A>>6VGTZ.VB-O;K$!'YMPDAX'.Y1SG&17ET7P8:*PM[7_A7_`,1G5Y=:
MBU?=<:,!K6FZI<3W%QI]P!>#,:R7&8W!WH4R#\[@_6=<S\2/B1X<^$?@O5/%
MGQ"U2WT?0M(A,MS=3'\`J@<L['`51DDD`"@#Q"X\,^*M9T+1?#OC#PO\1]>\
M,:%=6EQ%83-HT4M]]E=7MTO)UO?WRJ\<;$*B;R@W9&0<71OA?XAL_!%MX)U[
MPW\2-9\%V^H/>R:25T2V:[#7;77DSS+>EFB\QN0H4L!M)P2#^:?[8O\`P4L\
M=?M#ZK=:+\/;O4/!7@"*3;#9VDYBN]1`.1)<RH<X.`1&IVCON(S7RM_PLOQ?
M_P!#5XD_\&L__P`50!^\UIX*\2V%CK&@VGA3XB)X(UO5KC4KCP__`,24LC7$
MYN+B".Y%Z&6"25W8J5+`.RA@,8TO!>F>,OATCZ9X,\+>/['PK_:,E[!HTL>B
MS-9B65I9;>&<WH*PEW?`9&9`V%8`+C\OO^"5_C3Q#K?[9GA:UUG7M:O[5M.U
M(M!<ZA+*C$6LF,JS$'%?N5+_`*I_]TT`?/PL/%=AXA\<:_X8\(?$+2-8\;W&
MGSR3;M$N$LS:1)$%5&O/G61$(;)!&X[2#@UH>`_[<\"Z7KL$?PV\;WM[XGU2
M?5-6O/M&CP":YF1$9DC6\P@"QH`,DG;DDDDG^??Q%XX\1IX@U-4\0:X%6\E`
M']HR_P!\_P"U5&+Q_P"*()4E@\2:_')&P9'34I@5(Y!!W<&@#][_``?\.QX9
M^'U]X,U?X6^._$NAZEHFGZ/=PZC=:.OFQ6=JENC_`"7@PY"!\C!5L%2,`UF?
M#[X9^(_A(8)/AOX=^)MG<OIL5AJLFJOHVH#55A>5H9Y<WJ,+A!,R&0-AU"[E
M)`(^0OV(/^"KU_I=[I_@C]J2^:_TZ9U@L/&$@_?6Q)PJWF/OQ_\`37[PZMN&
M6'ZSVUS%>6\5Q:2QSP3H'BEC8,KJ1D,"."".<B@#E/AC)KTN@7#^,_[<%Z]_
M,T2:Q#91S1PD@HG^B.T950=H8G<<$D=*Z^BB@`HHHH`****`&331V\+RW#I%
M%$I9W=@JJH&223T&*_!3_@HE^V?>?M/_`!.FT?PK=R)\./"MR\6CPHQ"ZA*,
MJ]ZX[[N0@/W4]"S5^D/_``53_:`?X.?LU7VA:!>>1XA\?3#28O+?$D-HRL;F
M08.0"BF+/_37VK\)*`"BO3/@C\"-:^-LGB^;1F%MI?@?PQ?^(-7O77*Q16\+
MND8]7D=50#TW-T4UYG0!]A?\$G/^3U_"O_8-U/\`]))*_>.;_5/_`+IK\'/^
M"3G_`">OX5_[!NI_^DDE?O'-_JG_`-TT`?RU^)/^1BU3_K]F_P#0S6=6CXD_
MY&+5/^OV;_T,UJ?#+P6WQ'^(_A?PG'=+8OXFUBUTU;IDWB`SRK&'([@%LX]J
M`.:K]4O^"2?[:-S-=P_`_P")=^TT;1L_@Z]N),E-H+/8DGMM!:/TPR]T`_,[
MXA^`M9^%WCG7/"7C&U-GK7AZ^DL[R'.0'0XRI[J1A@>X(/>J'AGQ'J/@_P`1
MZ7KOARZDLM5T:\BO+*YC.&BFC<.C#Z,`:`/ZEJ*YWX=>.-/^)G@'P[XM\/OO
MTWQ)IEOJ%MSDA)8PX4^XS@^X-=%0`4444`%%%%`'XA_\%C?&TOB']JNVT,2L
M;;PMX;M+?RL\++*TD[-]2LL8_`5\)U]6_P#!4I)%_;I^)!D#!6723'GH5_LN
MT''MD']:^4J`/UO_`&+?A/;^"/\`@E_\6O%4D`75/'WAW7KJ28CYC;06TT$*
M?0,DSC_KH:_)"OW7^#MJ-0_X)0+;:0GFO/\`"[545%_BD,%P&'_?6:_"B@#[
M"_X).?\`)Z_A7_L&ZG_Z225^\<W^J?\`W37\_G_!-#QWHOP]_;'\$W_BZ]AT
MZPO1=Z>MU.X6..:>W>.(,QX`9RJY]6%?O1X[\9Z/\//!VL^)?&%]!INC:+9R
M7-Y<S.%5$52>_4GH!U)(`Y-`'\PWB3_D8M4_Z_9O_0S7>?LP?\G)?"K_`+'3
M2?\`TKBKSO5;L7^IWETBE5N9WD"GL&8G'ZUZ7^RE8S:E^TY\*+>T4O*_C/2B
M`/0749)_``F@#[,_X+3_``@MO#OQ2\'_`!"TNW6(>+]/DL=29!C?<VNW8[>Y
MBD5?I$*_-^OV%_X+=/"/@]\.D;;]H;Q+,8_78+9MWX9*_I7X]4`?O1_P2C\9
MR>+OV,?#-O<RF67PUJ%]I3,>H59C*B_@DR#Z`5]@5\!?\$5U=?V5O$QD#!6\
M?7A3/<?8;`<?B#7W[0`4444`%%%%`'XH?\%EO`%QH'[3&E^)HX&^P>*/#EL6
MG"G:;B%Y(F4GU\M8C]#7P-7[\?\`!2_]GV7X\_LR:PV@VIN?$G@V0:WIB(N7
MF6)6$\(QR2T3.0.[*HK\!Z`/VN_X)$?%33OB3^S#J/P]U=XY[[P7>SVTUI(0
M3)879:1&Q_=WM.GMM'J*_*C]J/X#ZI^S?\;_`!+X)UF*46]E<M-I-RXXO+&0
MDP2@]\K\I]&5AVJY^RA^TIK?[*_QATWQEX?5[NQQ]EUK3-^U=0LG(+QY[,"`
MRMV91U&0?V2^+_P9^$O_``4P^!NDZ_X8U:(7<<;-H?B&VC!N=,F(!DMKB/.2
MN<;XB1SAE/0D`_`JNBUGXD>+?$>B6VC>(?%'B+5-(L\?9["\U2::"''3;&S%
M5Q["O:_CC_P3^^-GP)U*X76?!^H>(='B8^5K7AZ%[ZVD3)PS!!OC^CJOXUXA
M9^`/%&H7@L[#PWKUS=EMH@ATV5Y,^FT+G-`&#7W;_P`$B_V?KWXC_M!+X_U&
MU?\`X1SX=QM,)V4[)M0E0I#&/4JK/*?3:F?O"L']F_\`X)9?%KXS:I:7?Q!T
MZY^'7A0LK7%WJT.V\F3@E8;8X?<1WDVJ.O/0_HO\;_C/\,?^":/[/=CX6^']
MI:G7&MG3P[H7F!Y[VX(P][=L,'9NY9SC<0$7'\(!\3_\%FOC-;>,?C5X<\`Z
M/<+-!X$T]Y=0V,"%O;K8Q0^ZQ)$?;S"*_/&M7Q7XIU7QOXFU7Q!XJO9M1UC6
MKN2\OKJ8Y:::1BS,?J2>.U7/AWX#U?XH>.M!\)>$K=KK6/$5_%96D8'&]V`W
M-Z*HRQ/8`GM0!^Z?_!+7P-)X)_8Q\'O=Q^5<>(Y[O5Y%QU669EB/XQ1QG\:^
MM*R?"?AG3_!7A?1_#_A^$6^F:'8PV-G$/X(8D"(/^^5%:U`!1110`4444`(1
MD<U^'7_!3+]B2Z^`/C^Y\>>`-/=OAUXJNS(RP)E=&O7)+0,!]V)CEHST'*?P
MC=^XU9/BOPIH_CKPWJ/A_P`8:;::OHNK6[6][8W<8>.>-NH(/Y@]00",$4`?
MRVU^D/\`P1B^&OC/5?B5XB\9V.LZKI7@71;?[)?6<4F+?6;V1?W<;J>#Y2DR
M%A\P+1C.&-9/[5__``24\9^!/$HU7]G2WN/%WA34KM4736D!OM)+L``V?];"
M"?OCYE`RPP"Q_4_]FSX&Z5^SE\&/#?@3P^(Y/[)M@U_=*N#>7C_-/,>_S.3C
M/10H[4`>G4F*6B@!&7<I`)7(QD=17\ZG[<_PV\9?"W]I?Q;I7Q0UC5?$=[<7
M'VS3]:U&0R2:A8R$F%\]!@`H57"JR,```*_HLKXO_P""GG[)-S^T9\(;?7_`
M>FO?>//!3&6QMX$S+J%HY'G6P'\3#B11ZJP'+T`?A/7["?\`!*']B>Y^'FF+
M\8_BCI[VWB#6K4Q^&;"X3#V-G(/FN74_=DE7A1U$9/\`?P,S]AG_`()3_P#"
M&ZGIWCS]IRWM+O5;5EGTSPF'6>&VD'*R7;#*R,#R(U)4'EBWW1^FW3I0`M%%
H%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
